Veracity Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $643K | Sell |
3,466
-666
| -16% | -$124K | 0.22% | 100 |
|
2025
Q1 | $866K | Sell |
4,132
-550
| -12% | -$115K | 0.34% | 63 |
|
2024
Q4 | $832K | Buy |
4,682
+338
| +8% | +$60.1K | 0.3% | 70 |
|
2024
Q3 | $858K | Sell |
4,344
-22
| -0.5% | -$4.35K | 0.33% | 60 |
|
2024
Q2 | $749K | Sell |
4,366
-939
| -18% | -$161K | 0.31% | 64 |
|
2024
Q1 | $966K | Sell |
5,305
-335
| -6% | -$61K | 0.38% | 57 |
|
2023
Q4 | $874K | Buy |
5,640
+170
| +3% | +$26.3K | 0.35% | 57 |
|
2023
Q3 | $815K | Buy |
5,470
+233
| +4% | +$34.7K | 0.38% | 54 |
|
2023
Q2 | $706K | Sell |
5,237
-78
| -1% | -$10.5K | 0.3% | 77 |
|
2023
Q1 | $847K | Sell |
5,315
-70
| -1% | -$11.2K | 0.39% | 53 |
|
2022
Q4 | $870K | Buy |
5,385
+52
| +1% | +$8.4K | 0.42% | 53 |
|
2022
Q3 | $716K | Buy |
5,333
+189
| +4% | +$25.4K | 0.39% | 56 |
|
2022
Q2 | $788K | Sell |
5,144
-2
| -0% | -$306 | 0.42% | 54 |
|
2022
Q1 | $834K | Buy |
5,146
+1,536
| +43% | +$249K | 0.35% | 65 |
|
2021
Q4 | $489K | Buy |
3,610
+196
| +6% | +$26.6K | 0.2% | 127 |
|
2021
Q3 | $368K | Sell |
3,414
-43,371
| -93% | -$4.68M | 0.16% | 145 |
|
2021
Q2 | $5.21M | Sell |
46,785
-64,660
| -58% | -$7.2M | 1.21% | 16 |
|
2021
Q1 | $823K | Buy |
111,445
+732
| +0.7% | +$5.41K | 0.18% | 142 |
|
2020
Q4 | $737K | Buy |
110,713
+41,422
| +60% | +$276K | 0.18% | 140 |
|
2020
Q3 | $771K | Sell |
69,291
-19,326
| -22% | -$215K | 0.21% | 112 |
|
2020
Q2 | $2.76M | Buy |
88,617
+62,690
| +242% | +$1.95M | 0.77% | 24 |
|
2020
Q1 | $1.98M | Buy |
25,927
+21,751
| +521% | +$1.66M | 0.57% | 34 |
|
2019
Q4 | $370K | Buy |
+4,176
| New | +$370K | 0.1% | 156 |
|